Intrawound vancomycin to prevent infections after spine surgery: a systematic review and meta-analysis
- 922 Downloads
Post-operative spine surgical site infections are associated with substantial morbidity, mortality, and economic burden. Intrawound vancomycin may prevent infections after spine surgery, but recent studies have reported conflicting results. The objectives of this systematic review and meta-analysis were to determine: (1) In patients undergoing spine surgery, does the application of intrawound vancomycin lead to reduced rates of post-operative surgical site infections? (2) Are there differences in the estimates of effect between observational studies and randomized trials? (3) What adverse events are reported in the literature?
All published comparative studies of intrawound vancomycin in spine surgery were included. Two reviewers independently screened eligible articles and assessed study quality. Observational studies and randomized trials were pooled separately using a random-effects model.
Eight observational studies and one randomized controlled trial met the inclusion criteria. Across observational studies, the odds of infection with intrawound vancomycin was 0.19 times the odds of infection without intrawound vancomycin (95 % CI 0.08–0.47, p = 0.0003, I 2 = 52 %). The single randomized controlled trial produced a conflicting result (OR 0.96, 95 % CI 0.34–2.66, p = 0.93). There were no adverse events attributable to intrawound vancomycin. The quality of the evidence was low or very low.
There is a lack of high-quality evidence to inform the use of intrawound vancomycin in spine surgery. Surgeons should be cautious before widely adopting this intervention and should be vigilant in monitoring for adverse effects. Further investigation with additional randomized controlled trials is justified.
KeywordsIntrawound vancomycin Infection Spine Evidence-based medicine Randomized trials
This study was not funded. Dr. Bhandari is funded, in part, by a Canada Research Chair.
Conflict of interest
The authors certify that they, or a member of their immediate families, have no funding or commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.
This study did not require local institutional ethics board approval.
- 13.Vitale MG, Riedel MD, Glotzbecker MP, Matsumoto H, Roye DP, Akbarnia BA, Anderson RC, Brockmeyer DL, Emans JB, Erickson M, Flynn JM, Lenke LG, Lewis SJ, Luhmann SJ, McLeod LM, Newton PO, Nyquist AC, Richards BS 3rd, Shah SA, Skaggs DL, Smith JT, Sponseller PD, Sucato DJ, Zeller RD, Saiman L (2013) Building consensus: development of a best practice guideline (BPG) for surgical site infection (SSI) prevention in high-risk pediatric spine surgery. J Pediatr Orthop 33(5):471–478CrossRefPubMedGoogle Scholar
- 20.Tubaki VR, Rajasekaran S, Shetty AP (2013) Effects of using intravenous antibiotic only versus local intrawound vancomycin antibiotic powder application in addition to intravenous antibiotics on postoperative infection in spine surgery in 907 patients. Spine (Phila Pa 1976) 38(25):2149–2155CrossRefGoogle Scholar
- 23.Chiang HY, Herwaldt L, Schweizer M (2014) Reply to “letter to the editor” by baker and chen regarding “effectiveness of local vancomycin powder to decrease surgical site infections: A meta-analysis”. Spine J [Epub ahead of print]Google Scholar
- 25.Higgins JPT, Greene S (2011) Cochrane handbook for systematic reviews of interventions. In: Higgins JPT and Greene S (eds). The cochrane collaboration, version 5.1.0 edGoogle Scholar
- 27.Sackett D, Haynes R, Guyatt G, Tugwell P (1991) Clinical epidemiology: a basic science for clinicians, 2nd edn. Little Brown, BostonGoogle Scholar
- 34.Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Schünemann HJ (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64(4):383–394CrossRefPubMedGoogle Scholar
- 37.Heller A, McIff TE, Lai SM, Burton DC (2013) Intrawound vancomycin powder decreases staphylococcal surgical site infections following posterior instrumented spinal arthrodesis. J Spinal Disord Tech [Epub ahead of print]Google Scholar
- 42.Walsh M, Srinathan SK, McAuley DF, Mrkobrada M, Levine O, Ribic C, Molnar AO, Dattani ND, Burke A, Guyatt G, Thabane L, Walter SD, Pogue J, Devereaux PJ (2014) The statistical significance of randomized controlled trial results is frequently fragile: A case for a fragility index. J Clin Epidemiol 67(6):622–628Google Scholar
- 43.Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, Devereaux PJ, Montori VM, Freyschuss B, Vist G, Jaeschke R, Williams JW Jr, Murad MH, Sinclair D, Falck-Ytter Y, Meerpohl J, Whittington C, Thorlund K, Andrews J, Schünemann HJ (2011) GRADE guidelines 6. Rating the quality of evidence–imprecision. J Clin Epidemiol 64(12):1283–1293CrossRefPubMedGoogle Scholar
- 44.Caroom C, Chaput CD, Tullar J, Jones J (2012) Reduced surgical site infections in patients with cervical spondylotic myelopathy undergoing posterior cervical instrumented fusion using vancomycin powder and chlorhexadine skin preparation. Spine J. Conference: 27th Annual Meeting of the North American Spine Society, NASS 2012 Dallas, TX United States. Conference Start: 20121024 Conference End: 20121027. Conference Publication: (var.pagings) 12(9 SUPPL. 1):80SGoogle Scholar
- 45.Dewan MC, Godil SS, Zuckerman SL, Mendenhall SK, Shau DN, Parker SL, Devin CJ, McGirt MJ (2013) Comparative effectiveness and cost-benefit analysis of topical vancomycin powder in posterior spinal fusion for spine trauma and degenerative spine disease. Spine J. Conference: 28th Annual Meeting of the North American Spine Society, NASS 2013 New Orleans, LA United States. Conference Start: 20131009 Conference End: 20131012. Conference Publication: (var.pagings). 13(9 SUPPL. 1):56SGoogle Scholar
- 46.Vancomycin in spine surgery [Internet]. 2013. Available from: http://clinicaltrials.gov/ct2/show/NCT01977989
- 47.Comparative effectiveness and cost-benefit analysis of vancomycin powder in high risk spine surgery patients [Internet]. 2013. Available from: http://clinicaltrials.gov/ct2/show/NCT01566422
- 48.Edin ML, Miclau T, Lester GE, Lindsey RW, Dahners LE (1996) Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res (333):245–251Google Scholar
- 56.Moore TJ (1995) Excess mortality estimates: dearly medicine: why tens of thousands of heart patients died in America’s worst drug disaster. Simon & Shuster, New YorkGoogle Scholar
- 58.Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. heart and estrogen/progestin replacement study (HERS) research group. JAMA 280(7):605–613CrossRefPubMedGoogle Scholar
- 60.Reichenbach S, Rutjes AW, Nuesch E, Trelle S, Juni P (2010) Joint lavage for osteoarthritis of the knee. Cochrane Database Syst Rev 12(5):CD007320Google Scholar
- 62.The EC/IC Bypass Study Group (1985) Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 313(19):1191–1200Google Scholar
- 64.Petignat C, Francioli P, Harbarth S, Regli L, Porchet F, Reverdin A, Rilliet B, de Tribolet N, Pannatier A, Pittet D, Zanetti G (2008) Cefuroxime prophylaxis is effective in noninstrumented spine surgery: a double-blind, placebo-controlled study. Spine (Phila Pa 1976) 33(18):1919–1924CrossRefGoogle Scholar